Jazz Pharmaceuticals (JAZZ) Interest Coverage Ratio (2010 - 2026)

Jazz Pharmaceuticals' Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 0.58 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 756.44% year-over-year to 0.58 in Q1 2026; TTM through Mar 2026 was 0.07, a 106.92% decrease from a year earlier, with the FY2025 full-year figure at 0.66, down 147.23% from the prior year.
• Interest Coverage Ratio fell to 0.58 in Q1 2026 per JAZZ's latest filing, from 8.13 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 23.19 in Q2 2024 and bottomed at 10.45 in Q4 2022.
• The 5-year median for Interest Coverage Ratio is 0.21 (2023), against an average of 1.35.
• Across the five-year window, Interest Coverage Ratio tumbled 622.8% in 2022 and surged 8976.91% in 2024, its largest moves.
• Year by year, Interest Coverage Ratio stood at 10.45 in 2022, then jumped by 103.71% to 0.39 in 2023, then soared by 57.62% to 0.61 in 2024, then soared by 1232.21% to 8.13 in 2025, then slumped by 92.85% to 0.58 in 2026.
• Per Business Quant, the three latest JAZZ Interest Coverage Ratio figures stand at 0.58 (Q1 2026), 8.13 (Q4 2025), and 0.09 (Q3 2025).